Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
72.56
-0.95 (-1.29%)
At close: Jul 19, 2024, 4:00 PM
72.40
-0.16 (-0.22%)
Pre-market: Jul 22, 2024, 5:26 AM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 83.31, with a low estimate of 69 and a high estimate of 105. The average target predicts an increase of 14.82% from the current stock price of 72.56.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GILD stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
Buy | 3 | 3 | 3 | 3 | 2 | 3 |
Hold | 7 | 7 | 10 | 10 | 11 | 11 |
Sell | 1 | 1 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 13 | 16 | 16 | 16 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Raymond James | Raymond James | Hold → Buy Upgrades $93 | Hold → Buy | Upgrades | $93 | +28.17% | Jul 8, 2024 |
RBC Capital | RBC Capital | Hold Reiterates $74 | Hold | Reiterates | $74 | +1.98% | Jul 1, 2024 |
Baird | Baird | Hold Maintains $80 | Hold | Maintains | $80 | +10.25% | Jun 20, 2024 |
RBC Capital | RBC Capital | Hold Reiterates $74 | Hold | Reiterates | $74 | +1.98% | Jun 14, 2024 |
Barclays | Barclays | Hold Maintains $80 → $76 | Hold | Maintains | $80 → $76 | +4.74% | Apr 29, 2024 |
Financial Forecast
Revenue This Year
28.14B
from 27.12B
Increased by 3.78%
Revenue Next Year
28.50B
from 28.14B
Increased by 1.27%
EPS This Year
3.83
from 4.50
Decreased by -14.90%
EPS Next Year
7.30
from 3.83
Increased by 90.65%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 29.5B | 30.4B | 31.6B | 33.1B | 35.7B |
Avg | 28.1B | 28.5B | 29.3B | 30.1B | 31.0B |
Low | 26.5B | 26.7B | 27.0B | 26.6B | 27.2B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.7% | 7.9% | 11.1% | 12.7% | 18.5% |
Avg | 3.8% | 1.3% | 2.9% | 2.7% | 3.0% |
Low | -2.4% | -5.2% | -5.2% | -9.5% | -9.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.13 | 8.42 | 9.05 | 9.66 | 10.33 |
Avg | 3.83 | 7.30 | 7.74 | 8.00 | 8.44 |
Low | 3.50 | 5.86 | 6.24 | 6.54 | 6.59 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -8.3% | 119.9% | 24.0% | 24.8% | 29.1% |
Avg | -14.9% | 90.6% | 6.0% | 3.4% | 5.5% |
Low | -22.3% | 53.0% | -14.5% | -15.6% | -17.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.